Identifying Needs and Opportunities to Improve Clinical Outcomes in the Identification, Characterization, and Management of Low-Grade Serous Ovarian Cancer

Identifying Needs and Opportunities to Improve Clinical Outcomes in the Identification, Characterization, and Management of Low-Grade Serous Ovarian Cancer is organized by Med Learning Group.

Released Date: July 15, 2024
Expiration Date: July 15, 2025

Description:
This enduring educational activity will provide insight into evidence-based approaches for clinical and pathological assessment of patients with demonstrated/suspected low-grade serous ovarian cancer (LGSOC). It will also present efficacy and safety considerations for available therapeutic options in the management of LGSOC and the latest evidence regarding novel targeted treatments for this condition, incorporating a detailed look at the clinical rational for RAF, MEK, and FAK inhibition.

Learning Objectives:
Upon the completion of this program, attendees should be able to:

• Recognize the need for improved diagnosis and recognition of the clinical and genomic features of low-grade serous ovarian cancer (LGSOC) to better address disease burden
• Review efficacy and safety data for available therapeutic options in the management of LGSOC and needs for novel targeted management
• Analyze the latest clinical data informing the safety and efficacy of novel targeted treatments—including RAF, MEK, and FAK—for the clinical management of LGSOCs.